跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CELAPRAM citalopram 20mg (as hydrobromide) tablet blister - TGA Drug Approval Details
Approvals
/
TGA
/
CELAPRAM citalopram 20mg (as hydrobromide) tablet blister
Approved
STANDARD
CELAPRAM citalopram 20mg (as hydrobromide) tablet blister
Alphapharm Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
cc4bd8ca33c0a110
Company
Alphapharm Pty Ltd
Type
Standard
Approval Details
Approval Id
cc4bd8ca33c0a110
Product Name
CELAPRAM citalopram 20mg (as hydrobromide) tablet blister
Artg Id
394031
Artg Name
CELAPRAM citalopram 20mg (as hydrobromide) tablet blister
Sponsor
Alphapharm Pty Ltd
Company Detail Path
/organization/alphapharm-pty-ltd
Artg Date
2022-08-17
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
cc4bd8ca33c0a110
Type
Standard
Back to TGA Approvals
